| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817711 | Clinical Biochemistry | 2014 | 4 Pages |
Abstract
This finding may be relevant for pathological conditions associated with increased cfDNA concentrations like cystic fibrosis, where pharmacological recombinant human DNase (rhDNase) treatment has been successfully used to improve patients' health and physical function.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Martina Velders, Gunnar Treff, Katja Machus, Edit Bosnyák, Jürgen Steinacker, Uwe Schumann,